20 Recruiting Prostate Cancer (Adenocarcinoma) Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by Study Phase
Top Recruiting Prostate Cancer (Adenocarcinoma) Studies
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
📍 City of Hope — Duarte, California
View Study & Checklist ➔Adaptive Radiation Therapy for Men With Intermediate- or High-Risk Prostate Cancer
📍 Fox Chase Cancer Center — Philadelphia, Pennsylvania
View Study & Checklist ➔Micro-ultrasound-Guided Focal Laser Ablation for Intermediate-Risk Prostate Cancer: Safety & Effectiveness
📍 University Health Network - Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔Molecular Imaging Informed Radiation Dose Escalation to Sites of Recurrent Disease and De-escalation to Uninvolved Areas in Salvage Radiotherapy Using SBRT for Prostate Cancer to Reduce Treatment Toxicity
📍 University Health Network - Princess Margaret Cancer Center — Toronto, Ontario
View Study & Checklist ➔Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
📍 Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland
View Study & Checklist ➔Flotufolastat F 18 PET in Men With Very Low PSA Recurrence
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer
📍 University of Chicago Medicine, High-Risk and Advanced Prostate Cancer Clinic — Chicago, Illinois
View Study & Checklist ➔68Ga-PSMA-11 PET/MRI for Selecting Men With Prostate Cancer for Focal Therapy
📍 University Health Network - Princess Margaret Cancer Centre — Toronto, Ontario
View Study & Checklist ➔PSMA PET for Surveillance After Focal Therapy
📍 University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
View Study & Checklist ➔Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
📍 University of California San Diego, Moores Cancer Center — La Jolla, California
View Study & Checklist ➔PRIAPUS-PCa Study: Stereotactic Body Radiation Therapy (SBRT) and Androgen Deprivation Therapy (ADT) Impact on Sexual Function on Men With Unfavorable Intermediate Risk Prostate Cancer
📍 Manitoba Prostate Centre — Winnipeg, Manitoba
View Study & Checklist ➔Optimal Duration of Hormonal Therapy for Unfavorable Intermediate-risk Prostate Cancer Patients: 6 Versus 12 Months.
📍 Hôpital de Gatineau — Gatineau, Quebec
View Study & Checklist ➔Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
📍 Houston Methodist — Houston, Texas
View Study & Checklist ➔Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
📍 Anchorage Associates in Radiation Medicine — Anchorage, Alaska
View Study & Checklist ➔